Posted on 7/31/19
Vor Biopharma Appoints Dr. Bill Lundberg to Its Board of Directors
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of hematological cancers
Posted on 7/31/19
Abacus Health Products Appoints Hannan Fleiman to Board
Abacus Health Products, Inc. (CSE: ABCS) (OTCQX: ABAHF) is pleased to announce that Mr. Hannan Fleiman has joined its board of directors.
Posted on 7/29/19
Verastem Oncology Appoints Brian Stuglik as CEO
Verastem, Inc. (Nasdaq: VSTM), a biopharmaceutical company focused on developing and commercializing medicines seeking to
Posted on 7/29/19
Compass Diversified Holdings Appoints Larry Enterline and D. Eugene Ewing to Board
Compass Diversified Holdings (NYSE: CODI), an owner of leading middle market businesses, announced today that Larry L. Enterline
Posted on 7/29/19
Unum Therapeutics Appoint Arlene Morris and Matthew Ros To Board
Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer
Posted on 7/28/19
Michael Ambrose Nominated to Join RBC Bearings Board of Directors
RBC Bearings Incorporated (Nasdaq: ROLL), a leading international manufacturer of highly-engineered precision
Posted on 7/26/19
Sarah Hlavinka Elected to Quanterix Board of Directors
Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision
Posted on 7/26/19
IDG Names Mohamad Ali as CEO
International Data Group, Inc. (IDG) today announced that Mohamad Ali has been named CEO of IDG. He will assume his new role on
Posted on 7/26/19
Intervention Insights Appoints Chet Burrell to Board
Intervention Insights announces the appointment of Chet Burrell as its Executive Chairman to support the continued growth of its distinct, precision diagnostic platform Trapelo.
Posted on 7/26/19
Carbonite Names Steve Munford Interim CEO
Carbonite, Inc. (NASDAQ: CARB), a global leader in data protection, today announced that Steve Munford
Posted on 7/25/19
Arvinas Adds Leslie Norwalk to Board
Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, announced today that Leslie Norwalk, Esq.,
Posted on 7/25/19
Vertex Announces Dr. Jeffrey Leiden to Transition to Role of Executive Chairman
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its Board of Directors has approved the planned transition of Chairman, President
Posted on 7/25/19
Synchrony Elects Fernando Aguirre to Board of Directors
Synchrony (NYSE: SYF), one of the nation's premier consumer financial services companies, today elected Fernando Aguirre
Posted on 7/24/19
Bicycle Therapeutics Enhances Board of Directors
Bicycle Therapeutics plc, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology,
Posted on 7/24/19
Rhythm Pharmaceuticals Appoints Stuart Arbuckle To Board
Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics
Posted on 7/24/19
Louisiana-Pacific CEO Brad Southern Named 2019 North American CEO of the Year
Fastmarkets RISI, the definitive source of commodity data and insights for the forest products industry, has announced that Brad Southern, Chief Executive Officer of Louisiana-Pacific Corporation . . .
Posted on 7/24/19
Kintai Therapeutics Appoints Mary Szela to Board
Kintai Therapeutics, a Flagship Pioneering company, today announced that Mary Szela, chief executive officer and president
Posted on 7/22/19
Disarm Therapeutics Appoints Dr. Alvin Shih as CEO
Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease
Posted on 7/22/19
Exicure Appoints Jeffrey L. Cleland and Tim Walbert to Board of Directors
Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid constructs
Posted on 7/19/19
Bain Capital Specialty Finance Appoints Amy Butte and Clare Richer to Board
Bain Capital Specialty Finance, Inc. (NYSE:BCSF) today announced the appointment of Amy Butte and Clare Richer to its Board of Directors.
Posted on 7/19/19
IDEXX Laboratories Elects Sam Samad to Board of Directors
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing
Posted on 7/18/19
Relay Therapeutics Names Doug Ingram and Deep Nishar to Its Board of Directors
Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced the appointment of Douglas S. Ingram
Posted on 7/17/19
Leslie Dan Retires From Sesen Bio Board
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment
Posted on 7/17/19
Pandion Therapeutics Appoints Rahul Kakkar as CEO
Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation for autoimmune diseases
Posted on 7/17/19
Snyk Names Peter McKay CEO
Developer-first security company, Snyk, has appointed Board Member and Advisor Peter McKay as Chief Executive Officer effective September 1, 2019.
Boston
